Konate, S.; Allangba, K.N.P.G.; Fofana, I.; N’Guessan, R.K.; Megnassan, E.; Miertus, S.; Frecer, V.
Improved Inhibitors Targeting the Thymidylate Kinase of Multidrug-Resistant Mycobacterium tuberculosis with Favorable Pharmacokinetics. Life 2025, 15, 173.
https://doi.org/10.3390/life15020173
AMA Style
Konate S, Allangba KNPG, Fofana I, N’Guessan RK, Megnassan E, Miertus S, Frecer V.
Improved Inhibitors Targeting the Thymidylate Kinase of Multidrug-Resistant Mycobacterium tuberculosis with Favorable Pharmacokinetics. Life. 2025; 15(2):173.
https://doi.org/10.3390/life15020173
Chicago/Turabian Style
Konate, Souleymane, Koffi N’Guessan Placide Gabin Allangba, Issouf Fofana, Raymond Kre N’Guessan, Eugene Megnassan, Stanislav Miertus, and Vladimir Frecer.
2025. "Improved Inhibitors Targeting the Thymidylate Kinase of Multidrug-Resistant Mycobacterium tuberculosis with Favorable Pharmacokinetics" Life 15, no. 2: 173.
https://doi.org/10.3390/life15020173
APA Style
Konate, S., Allangba, K. N. P. G., Fofana, I., N’Guessan, R. K., Megnassan, E., Miertus, S., & Frecer, V.
(2025). Improved Inhibitors Targeting the Thymidylate Kinase of Multidrug-Resistant Mycobacterium tuberculosis with Favorable Pharmacokinetics. Life, 15(2), 173.
https://doi.org/10.3390/life15020173